ARTIFICIAL INTELLIGENCE Â SARS COVID RISK EVALUATION (AI-SCORE) (Q4201930): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: Setting new description)
(‎Changed label, description and/or aliases in en, and other parts: Adding English translations)
label / enlabel / en
 
ARTIFICIAL INTELLIGENCE Â SARS COVID RISK EVALUATION (AI-SCORE)
Property / summary
 
THE FOCUS OF THE PROJECT IS TO QUICKLY FORMULATE:- A RISK SCORE FOR AN ASYMPTOMATIC SUBJECT TO ACHIEVE A COVID-19, OF WHAT EXTENT AND WITH WHAT POSSIBLE COMPLICATIONS; — A RAPID ASSESSMENT OF SYMPTOMATIC COVID-19 PATIENTS BY ASSESSING THE RISK OF COMPLICATIONS, THE NEED FOR INTENSIVE CARE AND MORTALITÃ.TO THIS END WE WILL BENEFIT FROM THE EXPERIENCE GAINED IN THE MANAGEMENT OF PATIENTS HOSPITALISED DURING THE CURRENT EPIDEMIC. THE SYSTEMISATION OF THE CLINICAL DATA OF THESE PATIENTS, OBTAINED FROM HETEROGENEOUS SOURCES, SUCH AS IMAGING DIAGNOSTICS, CLINICAL PARAMETERS, CYTOKINE PROFILE, GENOMIC PROFILE OF PATIENTS AND VIRUSES, WILL BE PURSUED THROUGH AN ADVANCED MULTIDIMENSIONAL ANALYSIS.TO THIS END, THE PROJECT HAS THE IMPORTANT OBJECTIVE OF CREATING A PLATFORM FOR THE DEFINITION OF DIAGNOSTICS AND PROGNOSTIC SCORES FOR COVID-19 SUBJECTS AND PREDICTION OF DISEASE RISK IN SANI SUBJECTS.THE PROJECT FORESEES 4 PHASES (English)
Property / summary: THE FOCUS OF THE PROJECT IS TO QUICKLY FORMULATE:- A RISK SCORE FOR AN ASYMPTOMATIC SUBJECT TO ACHIEVE A COVID-19, OF WHAT EXTENT AND WITH WHAT POSSIBLE COMPLICATIONS; — A RAPID ASSESSMENT OF SYMPTOMATIC COVID-19 PATIENTS BY ASSESSING THE RISK OF COMPLICATIONS, THE NEED FOR INTENSIVE CARE AND MORTALITÃ.TO THIS END WE WILL BENEFIT FROM THE EXPERIENCE GAINED IN THE MANAGEMENT OF PATIENTS HOSPITALISED DURING THE CURRENT EPIDEMIC. THE SYSTEMISATION OF THE CLINICAL DATA OF THESE PATIENTS, OBTAINED FROM HETEROGENEOUS SOURCES, SUCH AS IMAGING DIAGNOSTICS, CLINICAL PARAMETERS, CYTOKINE PROFILE, GENOMIC PROFILE OF PATIENTS AND VIRUSES, WILL BE PURSUED THROUGH AN ADVANCED MULTIDIMENSIONAL ANALYSIS.TO THIS END, THE PROJECT HAS THE IMPORTANT OBJECTIVE OF CREATING A PLATFORM FOR THE DEFINITION OF DIAGNOSTICS AND PROGNOSTIC SCORES FOR COVID-19 SUBJECTS AND PREDICTION OF DISEASE RISK IN SANI SUBJECTS.THE PROJECT FORESEES 4 PHASES (English) / rank
 
Normal rank
Property / summary: THE FOCUS OF THE PROJECT IS TO QUICKLY FORMULATE:- A RISK SCORE FOR AN ASYMPTOMATIC SUBJECT TO ACHIEVE A COVID-19, OF WHAT EXTENT AND WITH WHAT POSSIBLE COMPLICATIONS; — A RAPID ASSESSMENT OF SYMPTOMATIC COVID-19 PATIENTS BY ASSESSING THE RISK OF COMPLICATIONS, THE NEED FOR INTENSIVE CARE AND MORTALITÃ.TO THIS END WE WILL BENEFIT FROM THE EXPERIENCE GAINED IN THE MANAGEMENT OF PATIENTS HOSPITALISED DURING THE CURRENT EPIDEMIC. THE SYSTEMISATION OF THE CLINICAL DATA OF THESE PATIENTS, OBTAINED FROM HETEROGENEOUS SOURCES, SUCH AS IMAGING DIAGNOSTICS, CLINICAL PARAMETERS, CYTOKINE PROFILE, GENOMIC PROFILE OF PATIENTS AND VIRUSES, WILL BE PURSUED THROUGH AN ADVANCED MULTIDIMENSIONAL ANALYSIS.TO THIS END, THE PROJECT HAS THE IMPORTANT OBJECTIVE OF CREATING A PLATFORM FOR THE DEFINITION OF DIAGNOSTICS AND PROGNOSTIC SCORES FOR COVID-19 SUBJECTS AND PREDICTION OF DISEASE RISK IN SANI SUBJECTS.THE PROJECT FORESEES 4 PHASES (English) / qualifier
 
point in time: 1 February 2022
Timestamp+2022-02-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 06:34, 1 February 2022

Project Q4201930 in Italy
Language Label Description Also known as
English
ARTIFICIAL INTELLIGENCE Â SARS COVID RISK EVALUATION (AI-SCORE)
Project Q4201930 in Italy

    Statements

    0 references
    203,420.0 Euro
    0 references
    406,840.0 Euro
    0 references
    50.0 percent
    0 references
    PORINI S.R.L.
    0 references
    OROBIX S.R.L.
    0 references
    CENTRO CARDIOLOGICO SPA <FONDAZIONE MONZINO> IN FORMA ABBREVIATA CENTRO CARDIOLOGICO MONZINO SPA
    0 references
    UNIVERSITA' VITA-SALUTE S. RAFFAELE
    0 references
    ASST DI BERGAMO EST
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    IL FOCUS DEL PROGETTO Ê ARRIVARE A FORMULARE IN TEMPI RAPIDI:- UNO SCORE DI RISCHIO PER UN SOGGETTO ASINTOMATICO DI CONSEGUIRE UNA COVID-19, DI CHE ENTITà E CON QUALI POSSIBILI COMPLICAZIONI; - UNA RAPIDA VALUTAZIONE DI PAZIENTI COVID-19 SINTOMATICI VALUTANDO IL RISCHIO DI COMPLICAZIONI, DI NECESSITà DI CURE INTENSIVE E DI MORTALITà .A QUESTO SCOPO CI AVVANTAGGEREMO DELL ESPERIENZA ACQUISITA NELLA GESTIONE DEI PAZIENTI RICOVERATI NEGLI OSPEDALI DURANTE L ATTUALE EPIDEMIA. LA SISTEMATIZZAZIONE DEI DATI CLINICI DI QUESTI PAZIENTI, OTTENUTI DA SORGENTI ETEROGENEE, QUALI DIAGNOSTICA PER IMMAGINI, PARAMETRI CLINICI, PROFILO DI CITOCHINE, PROFILO GENOMICO DEI PAZIENTI E DEI VIRUS, SARà PERSEGUITA MEDIANTE UN ANALISI AVANZATA MULTIDIMENSIONALE.A TAL FINE, IL PROGETTO SI PONE L OBIETTIVO IMPORTANTE DI CREARE UNA PIATTAFORMA DI AI PER LA DEFINIZIONE DI DIAGNOSTIC E PROGNOSTIC SCORES PER SOGGETTI COVID-19 E LA PREVISIONE DEL RISCHIO DI MALATTIA IN SOGGETTI SANI.IL PROGETTO PREVEDE 4 FASI (Italian)
    0 references
    THE FOCUS OF THE PROJECT IS TO QUICKLY FORMULATE:- A RISK SCORE FOR AN ASYMPTOMATIC SUBJECT TO ACHIEVE A COVID-19, OF WHAT EXTENT AND WITH WHAT POSSIBLE COMPLICATIONS; — A RAPID ASSESSMENT OF SYMPTOMATIC COVID-19 PATIENTS BY ASSESSING THE RISK OF COMPLICATIONS, THE NEED FOR INTENSIVE CARE AND MORTALITÃ.TO THIS END WE WILL BENEFIT FROM THE EXPERIENCE GAINED IN THE MANAGEMENT OF PATIENTS HOSPITALISED DURING THE CURRENT EPIDEMIC. THE SYSTEMISATION OF THE CLINICAL DATA OF THESE PATIENTS, OBTAINED FROM HETEROGENEOUS SOURCES, SUCH AS IMAGING DIAGNOSTICS, CLINICAL PARAMETERS, CYTOKINE PROFILE, GENOMIC PROFILE OF PATIENTS AND VIRUSES, WILL BE PURSUED THROUGH AN ADVANCED MULTIDIMENSIONAL ANALYSIS.TO THIS END, THE PROJECT HAS THE IMPORTANT OBJECTIVE OF CREATING A PLATFORM FOR THE DEFINITION OF DIAGNOSTICS AND PROGNOSTIC SCORES FOR COVID-19 SUBJECTS AND PREDICTION OF DISEASE RISK IN SANI SUBJECTS.THE PROJECT FORESEES 4 PHASES (English)
    1 February 2022
    0 references
    GORGONZOLA
    0 references
    MILANO
    0 references
    BERGAMO
    0 references
    SERIATE
    0 references

    Identifiers